Stryker (SYK) Amortizatization of Intangibles (2009 - 2023)
Stryker's (SYK) quarterly Amortizatization of Intangibles came in at $149.0 million in Q4 2023, down 5.7% year-on-year from $158.0 million in Q4 2022, and down 9.15% on a QoQ basis from $164.0 million in Q3 2023.
Stryker (SYK) Amortizatization of Intangibles (2009 - 2023) Analysis & Trends
Stryker (SYK) has 15 years of Amortizatization of Intangibles data on file, last reported at $149.0 million in Q4 2023.
- On a quarterly basis, Amortizatization of Intangibles fell 5.7% year-over-year to $149.0 million in Q4 2023; TTM through Dec 2023 was $635.0 million, a 1.28% increase from a year earlier, with the FY2025 full-year figure at $732.0 million, up 17.5% from the prior year.
- Amortizatization of Intangibles for Q4 2023 stood at $149.0 million, down from $164.0 million in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for SYK reached as high as $181.0 million in Q1 2021 and fell as low as $110.0 million in Q2 2020.
- Historically, Amortizatization of Intangibles has averaged $140.8 million across 5 years, with a median of $147.0 million in 2021.
- Across the five-year window, Amortizatization of Intangibles jumped 53.39% in 2021 and declined 17.13% in 2022, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $112.0 million in 2019, then gained by 16.07% to $130.0 million in 2020, then grew by 11.54% to $145.0 million in 2021, then gained by 8.97% to $158.0 million in 2022, then retreated by 5.7% to $149.0 million in 2023.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $149.0 million in Q4 2023, $164.0 million in Q3 2023, and $161.0 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 149.00 Mn |
| Dec 31, 2023 | 149.00 Mn |
| Sep 30, 2023 | 164.00 Mn |
| Sep 30, 2023 | 164.00 Mn |
| Jun 30, 2023 | 161.00 Mn |
| Jun 30, 2023 | 161.00 Mn |
| Mar 31, 2023 | 161.00 Mn |
| Mar 31, 2023 | 161.00 Mn |
| Dec 31, 2022 | 158.00 Mn |
| Dec 31, 2022 | 158.00 Mn |
| Sep 30, 2022 | 159.00 Mn |
| Sep 30, 2022 | 159.00 Mn |
| Jun 30, 2022 | 160.00 Mn |
| Jun 30, 2022 | 160.00 Mn |
| Mar 31, 2022 | 150.00 Mn |
| Mar 31, 2022 | 150.00 Mn |
| Dec 31, 2021 | 145.00 Mn |
| Dec 31, 2021 | 145.00 Mn |
| Sep 30, 2021 | 144.00 Mn |
| Sep 30, 2021 | 144.00 Mn |